General Information of Drug (ID: DMIZB81)

Drug Name
Pyrazine-2-carboxylic acid adamantan-1-ylamide Drug Info
Synonyms
CHEMBL253348; Pyrazine-2-carboxylic acid adamantan-1-ylamide; BAS 03365795; AC1MG7YQ; Cambridge id 7248781; Oprea1_265306; Oprea1_647087; MLS000088554; cid_2931812; MolPort-001-540-487; HMS2379I12; ZINC4197514; N-adamantanylpyrazin-2-ylcarboxamide; N-1-adamantyl-2-pyrazinecarboxamide; BDBM50231727; STK431969; AKOS000665660; N-(1-adamantyl)pyrazine-2-carboxamide; SDCCGMLS-0024327.P002; MCULE-4724742312; SMR000071836; ST50923663
Indication
Disease Entry ICD 11 Status REF
Discovery agent N.A. Investigative [1]
Cross-matching ID
PubChem CID
2931812
TTD Drug ID
DMIZB81

Molecule(s) Related to This Drug


Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Metabotropic glutamate receptor 1 (mGluR1) TTVBPDM GRM1_HUMAN Inhibitor [1]

The Expression Level of Molecule(s) in Normal Tissue of Major ADME-Related Organs

Molecule Molecule Type Gene Name Liver Colon Kidney Small Intestine
Metabotropic glutamate receptor 1 (mGluR1) DTT GRM1 3.888 3.848 3.711 3.678
Molecule Expression Atlas in Normal Tissue of Major ADME-related organs

The Expression Level of Molecule(s) between Disease Section and Healthy Individual Tissue

The Studied Disease Discovery agent
ICD Disease Classification N.A.
Molecule Name Molecule Type Gene Name p-value Fold-Change Z-score
Metabotropic glutamate receptor 1 (mGluR1) DTT GRM1 2.31E-01 -0.05 -0.2
Metabotropic glutamate receptor 1 (mGluR1) DTT GRM1 2.46E-02 0.11 0.74
Molecular Expression Atlas between Disease Section and Healthy Individual Tissue

References

1 Positive and negative modulation of group I metabotropic glutamate receptors. J Med Chem. 2008 Feb 14;51(3):634-47.